Theriva Biologics, Inc. (TOVX): Operating Cash Flow
-$16.67M
Year ended 2025-12-31
-$12.74M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$16.67M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$16.94M | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$19.00M | n/m | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | -$19.08M | n/m | 2024-03-25, From 2022-01-01 |
| 2021-12-31 | -$12.89M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$12.17M | n/m | 2022-03-16, From 2020-01-01 |
| 2019-12-31 | -$13.87M | n/m | 2021-03-04, From 2019-01-01 |
| 2018-12-31 | -$17.28M | n/m | 2020-02-20, From 2018-01-01 |
| 2017-12-31 | -$20.20M | n/m | 2019-02-27, From 2017-01-01 |
| 2016-12-31 | -$27.90M | n/m | 2018-02-22, From 2016-01-01 |
| 2015-12-31 | -$38.89M | n/m | 2018-02-22, From 2015-01-01 |
| 2014-12-31 | -$16.08M | n/m | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | -$7.72M | n/m | 2016-03-10, From 2013-01-01 |
| 2012-12-31 | -$8.92M | n/m | 2015-03-16, From 2012-01-01 |
| 2011-12-31 | -$2.88M | n/m | 2013-04-16, From 2011-01-01 |
| 2010-12-31 | -$1.15M | n/a | 2012-05-11, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Theriva Biologics, Inc. (TOVX) | 2025-12-31 | -$16.67M | n/m |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | -$23.69M | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $2.45M | +109.7% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | -$4.02M | n/m |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | -$21.69M | n/m |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | -$57.62M | n/m |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | -$9.90M | n/m |
| Tvardi Therapeutics, Inc. (TVRD) | 2025-12-31 | -$23.50M | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | -$9.81M | n/m |
Compare TOVX, JAGX, TXMD, SXTC side by side · Screen every company in Pharmaceutical Preparations ↗